Reaction

Stasis Dermatitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 677 reports · 9 co-occurring drugs

As of the last recalculation, Stasis Dermatitis appears in 677 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is CAPTOPRIL (PRR 45.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Captopril1445.745.8
Felodipine Extended-Release Tablets1438.638.6
Felodipine1438.638.6
Nebivolol1427.627.6
Torsemide2827.127.1
Candesartan2926.126.1
Metolazone924.925.0
Pemetrexed Disodium2520.920.9
Pemetrexed1319.019.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.